Novartis

Novartis Completes Acquisition of Tourmaline Bio to Strengthen Cardiovascular Pipeline

Novartis Completes Acquisition of Tourmaline Bio to Strengthen Cardiovascular Pipeline

29 Oct 2025

2 min read

Novartis to Acquire Avidity Biosciences, Expanding Leadership in RNA Therapeutics for Neuromuscular Diseases

Novartis to Acquire Avidity Biosciences, Expanding Leadership in RNA Therapeutics for Neuromuscular Diseases

27 Oct 2025

2 min read

Novartis V-DIFFERENCE Study Shows Leqvio Helps 85% of Patients Reach LDL-C Targets

Novartis V-DIFFERENCE Study Shows Leqvio Helps 85% of Patients Reach LDL-C Targets

01 Sep 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com